Document is current
Any future updates will be listed below
-
Authors
Friedman, Jonathan M. https://orcid.org/0000-0001-5622-3500
Diaz, Luis E.
Roemer, Frank W.
Guermazi, Ali
- License Information
-
More Information
Article History
Received: 2 June 2022
Accepted: 26 December 2022
First Online: 6 January 2023
Declarations
:
: The authors declare that they have no conflicts of interests related to this work. Ali Guermazi is Shareholder of BICL, LLC and Consultant to Pfizer, TissueGene, Regeneron, Novartis, MerckSerono and AstraZeneca. Frank Roemer is Shareholder of BICL, LLC and Consultant to Calibr.
: This article does not contain any studies with human participants or animals performed by any of the authors.
